Kleen Fabrics Partners with PurThread To Provide Permanent Protection Against Odor and Bacteria in Apparel Line for Men and Women

PALO ALTO, CA (PRWEB) DECEMBER 22, 2015

Kleen Fabrics, a new Silicon Valley-based athletic apparel company, announces a partnership with PurThread Technologies Inc., maker of next generation antimicrobial fibers and yarns, to provide permanent protection against odor and bacteria in Kleen Fabrics’ patented Kleen Silver line of activewear.

“Kleen Fabrics aims to provide the highest performing gear to athletes, fitness enthusiasts, medical professionals, and savvy millennials. People today are looking for their clothing to do more for them and to take them from the gym, to work, and everywhere in between,” said Sassan Golafshan, founder and CEO of Kleen Fabrics. “In developing Kleen Silver for those individuals, we conducted extensive research and testing and found PurThread to be the most powerful and durable antimicrobial, anti-odor technology available worldwide.”

The foundation of this partnership is PurThread’s silver-embedded yarn which, in a recent study by the University of Arizona, was shown to kill 99.99 percent of salmonella and other bacteria on its surface within two hours of contact. The silver, a safe, non-nano, ionic silver salt, is EPA registered, and will power Kleen Silver products with unprecedented technology that kills odor-causing bacteria on contact.

PurThread is the first to embed silver into the fiber itself before it is spun into yarn and woven into fabrics. This novel technology yields Kleen Silver intrinsic antimicrobial benefits that don’t wash off or wear away for the life of the fabric and don’t change the fabric’s physical characteristics, making Kleen Silver the most effective product of its kind on the market.

“We are excited to join with Kleen Fabrics to provide their customers a truly effective and lasting anti-odor solution that is as low maintenance as it is high performance,” said Lisa Grimes, CEO of PurThread. “The advanced PurThread technology allows customers to wear Kleen Silver apparel longer while washing it less.”

About Kleen Fabrics
Kleen Fabrics' new line of active wear for men and women provides unprecedented protection against odor causing bacteria. The patented Kleen Silver powered by PurThread technology has made Kleen Fabrics a global leader in smart fabrics. As the only apparel line guaranteed to eliminate bacteria for the lifetime of the product, Kleen Silver apparel is sought-after by athletes, medical professionals, and savvy millennials worldwide. Designed in the heart of Silicon Valley by a dedicated team of fitness enthusiasts, Kleen Fabrics is proud to be 100% made in the USA. For more information, visit http://www.kleenfabrics.com.

About PurThread
PurThread Technologies Inc. embeds powerful EPA-registered silver into the core of fiber to offer partners unmatched antimicrobial protection with enhanced performance for their textile products. PurThread yarns intrinsically protect fabrics from the effects of microbial contamination and reduce odor-causing bacteria, mold, mildew and fungus. PurThread protects a wide range of consumer, industrial and healthcare products from privacy curtains, scrubs and lab coats, to freshness products, such as performance athletic wear, socks and gear for emergency first responders and the military. The EPA has not yet reviewed any public health claims for PurThread. PurThread yarns are 100% Made in the USA. For more information, visit http://www.purthread.com.

PurThread Technologies Partners with Beacon Linens to Provide Durable Antimicrobial Protection to Healthcare and Household Bed Linens

Partnering with PurThread is the obvious next step for us, as we look to create linens that work harder to make our customers’ lives easier. The high performance and durability of PurThread’s antimicrobial protection will add another valuable and hard-working feature to our linen lines for healthcare and for the home,” said Tedd Smith, President of Beacon Linens.
Read More

Burlington Partners with PurThread Technologies to Provide Embedded Antimicrobial Protection to Fabrics

PurThread Technologies, Inc., maker of next generation antimicrobial fibers and yarns, announces a partnership with Burlington, a global diversified provider of textile solutions across performance and specialty apparel fabrics, active wear, advanced uniform fabrics, and technical fabrics, to provide antimicrobial and anti-odor protection to the global healthcare, industrial, and apparel markets.

Read More

University of Arizona Reveals 99.99% Antimicrobial Efficacy of Fiber Embedded with Silver at IDWeek 2014

"It is impressive to see this sort of activity in such a short time frame for an antimicrobial fabric,” said Charles Gerba, professor of microbiology at the University of Arizona and lead researcher on the study. “PurThread fabrics are some of the most active we have ever tested and we look forward to working with them on other studies."
Read More

PurThread Technologies Donates Medical Scrubs to Samaritan's Purse

“PurThread’s goal is ultimately to help provide better and safer healthcare environments for patients and healthcare workers,” said CEO Lisa Grimes. “As we work to achieve that goal, Samaritan’s Purse is bringing much-needed healthcare to people now, in some of the toughest places on earth. We’re proud to offer our support.”
Read More

Kodak and PurThread to Collaborate on Antimicrobial Surface Solutions for Healthcare and Military

“This JDA builds on our promising collaboration with PurThread to embed Kodak’s technology into fabrics,” said Tom McHugh, General Manager, Materials Technology & Business Development for Kodak’s Digital Printing & Enterprise segment. “The demand for antimicrobial surfaces is only going to grow in response to infection prevention efforts around the globe.”
Read More

Kodak and PurThread Collaborate on Antimicrobial Technology for Textiles

PurThread has obtained a globally exclusive agreement to embed Kodak’s antimicrobial agent into textile materials. PurThread’s 2013 TechAmerica Award-winning process embeds Kodak’s antimicrobial agent into synthetic fibers, before the fiber is spun into yarn and woven into fabric, ensuring that the antimicrobial effects of the fabric are uniform and constant throughout the life of the product. This proprietary antimicrobial technology is derived from Kodak’s longtime expertise related to the production of photosensitive materials for use in the production of photographic products.

Read More

PurThread Completes $7 Million Financing Round to Advance as High-Performance Textile Leader

Award-winning life science and high-performance textile company PurThread Technologies today announced that it has closed an equity round totaling just over $7 million. The investment was led by PurThread Board Chair, Richard S. Bodman, with a select group of experienced investors who share the company’s passion for reducing bioburden in the hospital environment. Funding will be put toward the growth, research and development of PurThread’s technologies.

Read More

PurThread Technologies Achieves bluesign® System Partner Status

The award-winning life science and high-performance fabric company PurThread Technologies is proud to announce that it has fully completed the process to be officially designated a bluesign system partner. This elite status ensures manufacturers, consumers and retailers alike that PurThread acts as a responsible part of the textile supply chain and works to continuously improve environmental performance, with a focus on a sustainable future. The bluesign system partner status signifies the high-performance textile technology with antimicrobial properties found in PurThread’s medical linens, apparel and home goods meets the strict safety and environmental requirements of the complete suite of bluesign criteria.

Read More

PurThread Wins 2013 American Technology Award

PurThread Technologies, a life science and performance fabric firm dedicated to developing textiles to reduce bioburden in the healthcare environment, has been awarded the 2013 American Technology Award in Advanced or Technology Manufacturing by the TechAmerica Foundation at a gala event last Thursday, June 20, 2013, in Washington, D.C. The American Technology Awards recognize the best products and services from across the technology industry, as evaluated by industry experts and technology leaders.

Read More

Study Finds PurThread Hospital Privacy Curtains Resist Superbug (VRE) Contamination 8 Times Better than Control Curtains

A first of its kind study conducted by the University of Iowa Carver College of Medicine found standard control curtains were 8 times more likely to be contaminated with the superbug vancomycin resistant enterrococus (VRE) than experimental PurThread privacy curtains which only had 1 positive VRE culture during the entire study.

Read More

Study Finds 92% of Hospital Privacy Curtains Contaminated with Pathogenic Bacteria Within One Week

For one person in 20, spending the night in a hospital will lead to an infection, according to the Centers for Disease Control and Prevention (CDC). Now, research recently published by the American Journal for Infection Control reveals 92% of hospital privacy curtains were contaminated with potentially dangerous bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and VRE (vancomycin-resistant enterococcus) within one week of being laundered.

Read More

Copper Surfaces Study Validates PurThread Technologies' Development Efforts to Reduce Bioburden on Soft Surfaces

Researchers at the Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, and Ralph H. Johnson VA Medical Center have presented results of a study, funded by the U.S. Department of Defense, that links a reduction in environmental bioburden with lower rates of hospital acquired infections (HAIs).

Read More

Study Shows Potential Pathogens Cling to Hospital Privacy Curtains; Contamination Occurs Quickly after Laundering

Within a week of being laundered, 92 percent of hospital privacy curtains were contaminated with potentially pathogenic bacteria such as MRSA (methicillin-resistant S. aureus) and VRE (vancomycin-resistant enterococcus), a new study performed at the University of Iowa Hospital in Iowa City, IA reports.

Read More